PTC Therapeutics to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference

Rhea-AI Summary

PTC Therapeutics will present a company overview at the 40th Annual J.P. Morgan Virtual Healthcare Conference on January 10, 2022, at 7:30 a.m. EST. The live webcast can be accessed on PTC's Investor Events and Presentations page and will be archived for 30 days. PTC Therapeutics focuses on developing and commercializing medicines for rare disorders, with a commitment to providing access to innovative treatments for patients in need.

SOUTH PLAINFIELD, N.J., Jan. 3, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the 40^th Annual J.P. Morgan Virtual Healthcare Conference on Monday, Jan. 10, at 7:30 a.m. EST.

The presentation will be webcast live on the Events and Presentations page on the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

 

View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-40th-annual-jp-morgan-virtual-healthcare-conference-301451249.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics present at the J.P. Morgan Healthcare Conference?

PTC Therapeutics will present on January 10, 2022, at 7:30 a.m. EST.

Where can I watch the PTC Therapeutics presentation?

The presentation can be watched live on PTC's Events and Presentations page or accessed later as an archived webcast for 30 days.

What is the focus of PTC Therapeutics?

PTC Therapeutics is focused on the discovery, development, and commercialization of medicines for patients with rare disorders.

What is the significance of the 40th Annual J.P. Morgan Healthcare Conference for PTC?

The conference is a platform for PTC to present its company overview and share insights on its pipeline and strategic initiatives.

How does PTC Therapeutics support patients with rare disorders?

PTC Therapeutics aims to provide access to best-in-class treatments and has a robust pipeline of transformative medicines for unmet medical needs.